tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INSM Stock Latest News

Insmed price target raised to $145 from $121 at Stifel
The FlyInsmed price target raised to $145 from $121 at Stifel
10h ago
INSM
Insmed price target raised to $139 from $126 at Truist
PremiumThe Fly
Insmed price target raised to $139 from $126 at Truist
12h ago
INSM
H.C. Wainwright doubles Insmed target to $240 on ‘pipeline-in-a-pill’ potential
PremiumThe Fly
H.C. Wainwright doubles Insmed target to $240 on ‘pipeline-in-a-pill’ potential
1d ago
PFE
CHRO
C3 AI downgraded, Capri upgraded: Wall Street’s top analyst calls
PremiumThe Fly
C3 AI downgraded, Capri upgraded: Wall Street’s top analyst calls
1d ago
AI
CB
Insmed price target raised to $140 from $133 at UBS
PremiumThe Fly
Insmed price target raised to $140 from $133 at UBS
2d ago
INSM
Insmed downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyInsmed downgraded to Equal Weight from Overweight at Morgan Stanley
2d ago
INSM
Insmed’s Brensocatib Approval Boosts Market Potential and Stock Valuation
Premium
Ratings
Insmed’s Brensocatib Approval Boosts Market Potential and Stock Valuation
2d ago
INSM
Insmed’s BRINSUPRI Approval and Strategic Pricing Justify Buy Rating and Increased Price Target
Premium
Ratings
Insmed’s BRINSUPRI Approval and Strategic Pricing Justify Buy Rating and Increased Price Target
2d ago
INSM
Insmed price target raised to $140 from $130 at Wells Fargo
PremiumThe Fly
Insmed price target raised to $140 from $130 at Wells Fargo
2d ago
INSM
Insmed price target raised to $138 from $120 at RBC Capital
PremiumThe Fly
Insmed price target raised to $138 from $120 at RBC Capital
2d ago
INSM
Brinsupri approval sets stage for next leg of Insmed growth, says BofA
PremiumThe Fly
Brinsupri approval sets stage for next leg of Insmed growth, says BofA
2d ago
INSM
Insmed Gains FDA Approval for BRINSUPRI
PremiumCompany Announcements
Insmed Gains FDA Approval for BRINSUPRI
2d ago
8K
INSM
Insmed trading resumes
PremiumThe FlyInsmed trading resumes
2d ago
INSM
Insmed announces FDA approval of Brinsupri for NCFB
Premium
The Fly
Insmed announces FDA approval of Brinsupri for NCFB
2d ago
INSM
Insmed trading halted, news pending
Premium
The Fly
Insmed trading halted, news pending
2d ago
INSM
Insmed’s Earnings Call Highlights Strong Portfolio and Growth
PremiumCompany Announcements
Insmed’s Earnings Call Highlights Strong Portfolio and Growth
3d ago
INSM
Insmed price target raised to $120 from $108 at RBC Capital
PremiumThe Fly
Insmed price target raised to $120 from $108 at RBC Capital
7d ago
INSM
Insmed price target raised to $133 from $124 at UBS
PremiumThe Fly
Insmed price target raised to $133 from $124 at UBS
7d ago
INSM
Insmed Positioned for Growth: Buy Rating Backed by Brensocatib Launch and Strong Pipeline
PremiumRatings
Insmed Positioned for Growth: Buy Rating Backed by Brensocatib Launch and Strong Pipeline
7d ago
INSM
Insmed Reports Strong Growth and Strategic Advances
PremiumCompany AnnouncementsInsmed Reports Strong Growth and Strategic Advances
7d ago
INSM
Insmed’s Strong Financial Performance and Promising Drug Pipeline Drive Buy Rating
Premium
Ratings
Insmed’s Strong Financial Performance and Promising Drug Pipeline Drive Buy Rating
7d ago
INSM
Insmed reports Q2 EPS ($1.70), consensus ($1.31)
Premium
The Fly
Insmed reports Q2 EPS ($1.70), consensus ($1.31)
8d ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >